These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 14727257)

  • 1. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.
    Kokame K; Miyata T
    Semin Hematol; 2004 Jan; 41(1):34-40. PubMed ID: 14727257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL
    Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM
    J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
    Soejima K; Nakagaki T
    Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
    Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
    Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
    Kokame K
    Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of recombinant human ADAMTS-13.
    Plaimauer B; Scheiflinger F
    Semin Hematol; 2004 Jan; 41(1):24-33. PubMed ID: 14727256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.
    Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13.
    Pimanda JE; Maekawa A; Wind T; Paxton J; Chesterman CN; Hogg PJ
    Blood; 2004 Jan; 103(2):627-9. PubMed ID: 14512317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Baillieres Clin Haematol; 1998 Jun; 11(2):509-14. PubMed ID: 10097823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.
    Antoine G; Zimmermann K; Plaimauer B; Grillowitzer M; Studt JD; Lämmle B; Scheiflinger F
    Br J Haematol; 2003 Mar; 120(5):821-4. PubMed ID: 12614216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity.
    Savasan S; Lee SK; Ginsburg D; Tsai HM
    Blood; 2003 Jun; 101(11):4449-51. PubMed ID: 12576319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAMTS13 and TTP.
    Zheng X; Majerus EM; Sadler JE
    Curr Opin Hematol; 2002 Sep; 9(5):389-94. PubMed ID: 12172456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura.
    Pimanda JE; Chesterman CN; Hogg PJ
    Eur J Haematol; 2003 Apr; 70(4):257-62. PubMed ID: 12656756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.
    Tersteeg C; Fijnheer R; Pasterkamp G; de Groot PG; Vanhoorelbeke K; de Maat S; Maas C
    Semin Thromb Hemost; 2016 Feb; 42(1):9-17. PubMed ID: 26595154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
    Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.
    Peyvandi F; Ferrari S; Lavoretano S; Canciani MT; Mannucci PM
    Br J Haematol; 2004 Nov; 127(4):433-9. PubMed ID: 15521921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.